• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Comparison of stroke recurrence between antiplatelet and closure therapy in cryptogenic stroke patients with patent foramen ovale and its influencing factors.
PMID: 32307231 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - April 15, 2020 Category: Internal Medicine Authors: Zhang C, Zheng L, Zhang Y, Guo H, Chi J Tags: Eur J Intern Med Source Type: research

Current evidence for closure of a patent foramen ovale for cryptogenic stroke prevention
Summary A patent foramen ovale (PFO) has long been implicated as a potential mechanism for cryptogenic stroke (CS), which accounts for up to 40% of all cases of ischaemic stroke. Although there is a strong association between a PFO and CS, there is less evidence that percutaneous closure of the defect, as opposed to medical therapy with antithrombotics or anticoagulants, is the most effective form of secondary prevention. The aim of this review is to examine the evidence comparing percutaneous closure with medical therapy, with a particular focus on three recently published randomised controlled trials.
Source: International Journal of Clinical Practice - December 22, 2013 Category: Internal Medicine Authors: E. Rhone, N. Chung, B. Clapp Tags: Review Article Source Type: research

Predictive value of free fatty acid levels in embolic stroke of undetermined source: A retrospective observational study
The present study aimed to investigate the predictive value of free fatty acid (FFA) in embolic stroke of undetermined source (ESUS) according to the presence of potential embolic sources (PES) after extensive etiologic evaluation. This was a retrospective observational study based on a single-center registry from January 2011 to July 2017. Stroke subtypes were determined through laboratory findings, brain, and angiographic imaging, carotid ultrasonography, transthoracic echocardiography, and 24-hour Holter monitoring. If ESUS was suspected, transesophageal echocardiography was additionally performed. Patients were classi...
Source: Medicine - October 2, 2020 Category: Internal Medicine Tags: Research Article: Observational Study Source Type: research

Large thrombus entrapped in a patent foramen ovale complicated by stroke and pulmonary embolism.
Authors: Szymańska UA, Rosiak M, Rozbicka J, Kosior DA PMID: 26200927 [PubMed - as supplied by publisher]
Source: Polskie Archiwum Medycyny Wewnetrznej - July 24, 2015 Category: Internal Medicine Tags: Pol Arch Med Wewn Source Type: research

Transcatheter patent foramen ovale closure versus standard medical therapy for prevention of recurrent stroke: Updated Meta-analysis with an importance on shunt size.
PMID: 30146180 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - August 23, 2018 Category: Internal Medicine Authors: Patel K, Doshi R, Goyal H, Shah P, Meraj P Tags: Eur J Intern Med Source Type: research

Patent Foramen Ovale and Ischemic Stroke in Patients With Pulmonary Embolism.
PMID: 31569246 [PubMed - in process]
Source: Annals of Internal Medicine - September 30, 2019 Category: Internal Medicine Authors: Le Moigne E, Jobic Y, Timsit S, Hoffmann C, Couturaud F Tags: Ann Intern Med Source Type: research

Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence.
PMID: 33253619 [PubMed - in process]
Source: Annals of Internal Medicine - December 1, 2020 Category: Internal Medicine Authors: Aggarwal G, Aggarwal S, Cohen M Tags: Ann Intern Med Source Type: research

Clinical Experience of Percutaneous Patent Foramen Ovale Closure using the Amplatzer PFO Occluder in Japanese Patients to Prevent the Recurrence of Cryptogenic Stroke
Conclusion: Percutaneous closure using Amplatzer PFO occluder is a safe procedure for Japanese patients However, further investigations with a larger sample and longer follow-up are needed to confirm this result.PMID:34024855 | DOI:10.2169/internalmedicine.7188-21
Source: Internal Medicine - May 24, 2021 Category: Internal Medicine Authors: Hiroya Takafuji Kotaro Obunai Yu Makihara Nahoko Kato Hiroyuki Watanabe Source Type: research

Pages: 1  2  3  4